ZAMBELLO, RENATO

ZAMBELLO, RENATO  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 388 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Imaging in Plasma-Cell Neoplasms: Italian Experts’ Recommendations 2026 Crimi, FilippoZambello, Renato + EUROPEAN JOURNAL OF HAEMATOLOGY - -
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow‐Up Study and Correlation With Therapeutic Response 2026 Briani, ChiaraRossato, MarcoVisentin, AndreaLibrizzi, GiovanniVianello, FabrizioZambello, RenatoTrentin, LivioSalvalaggio, AlessandroManara, Renzo + JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM - -
A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide 2025 Zambello, R. + CLINICAL AND EXPERIMENTAL MEDICINE - -
AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA 2025 Pavan, LauraZambello, Renato + MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES - -
Belamaf: Is Renal Toxicity an Overlooked Side Effect? 2025 Pavan, LauraZambello, Renato + BLOOD ADVANCES - -
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response 2025 Zambello, Renato + BLOOD NEOPLASIA - -
Clinicians’ Perspectives and Methodological Application of Fluorescence in situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report From the European Myeloma Network (EMN) Italy 2025 Zambello, Renato + CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - -
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 2025 Zambello, Renato + HAEMATOLOGICA - -
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 2025 Zambello, Renato + ANNALS OF HEMATOLOGY - -
Diagnostic Criteria for NK-Cell Large Granular Lymphocyte Leukemia: Validation Through a Multicentric International Study 2025 Gasparini, Vanessa RebeccaTeramo, AntonellaZambello, Renato + BLOOD ADVANCES - -
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma 2025 Zambello, Renato + CANCERS - -
Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH) 2025 Zambello, Renato + AMERICAN JOURNAL OF HEMATOLOGY - -
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 2025 Zambello, Renato + HAEMATOLOGICA - -
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients 2025 Zambello, Renato + HAEMATOLOGICA - -
NK-type large granular lymphocyte leukemia comes of age 2025 Teramo, AntonellaCalabretto, GiuliaRampazzo, ElisaBuson, ElenaZambello, Renato + HEMASPHERE - -
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients 2025 Zambello, R. + ESMO OPEN - -
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study 2025 Pizzi, MarcoFriziero, AlbertoBertozzi, IreneBinotto, GianniDei Tos, Angelo PaoloCeccato, JessicaCinetto, FrancescoPiazza, FrancescoVisentin, AndreaZambello, RenatoTrentin, LivioVianello, Fabrizio + JOURNAL OF CLINICAL MEDICINE - -
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients 2025 Zambello, Renato + EUROPEAN JOURNAL OF HAEMATOLOGY - -
Prognostic stratification of standard risk multiple myeloma defined by revised international scoring system 2025 Pavan, LauraTeramo, AntonellaCalabretto, GiuliaTrentin, LivioZambello, Renato + LEUKEMIA & LYMPHOMA - -
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework 2025 Zambello, Renato + BMC CANCER - -